Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haluska

Showing results (251-260 of 366) with videos related to

Pageof 37
Sort By:
Heart (British Cardiac Society)|May 4, 2015
Subclinical LV dysfunction and 10-year outcomes in type 2 diabetes mellitusDavid J Holland, Thomas H Marwick, Brian A Haluska, et al.
Biochemical and Biophysical Research Communications|March 20, 1999
Identification and mutation analysis of DOC-1R, a DOC-1 growth suppressor-related geneX Zhang, H Tsao, T Tsuji, et al.
Neoplasia (New York, N.Y.)|June 29, 2017
Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived XenograftsKristina A Butler, Xiaonan Hou, Marc A Becker, et al.
Cancer Chemotherapy and Pharmacology|August 4, 2009
Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinomaPaul Haluska, Frank Worden, David Olmos, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2010
Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot studySeymur Gahramanov, Ahmed M Raslan, Leslie L Muldoon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2012
IGFBP ratio confers resistance to IGF targeting and correlates with increased invasion and poor outcome in breast tumorsMarc A Becker, Xiaonan Hou, Sean C Harrington, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cellsH R Salih, S G Kosowski, V F Haluska, et al.
Nephrology (Carlton, Vic.)|July 3, 2015
Association between left ventricular global longitudinal strain, health-related quality of life and functional capacity in chronic kidney disease patients with preserved ejection fractionRathika Krishnasamy, Carmel M Hawley, Tony Stanton, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|September 6, 2019
Storage Primes Erythrocytes for Necroptosis and ClearanceWilliam D McCaig, Alexa L Hodges, Matthew A Deragon, et al.
Investigational New Drugs|September 2, 2011
Phase I study of temsirolimus in combination with EKB-569 in patients with advanced solid tumorsAlan H Bryce, Ravi Rao, Jann Sarkaria, et al.
Pageof 37

Showing results (251-260 of 366) with videos related to

Sort By:
Pageof 37
Heart (British Cardiac Society)|May 4, 2015
Subclinical LV dysfunction and 10-year outcomes in type 2 diabetes mellitusDavid J Holland, Thomas H Marwick, Brian A Haluska, et al.
Biochemical and Biophysical Research Communications|March 20, 1999
Identification and mutation analysis of DOC-1R, a DOC-1 growth suppressor-related geneX Zhang, H Tsao, T Tsuji, et al.
Neoplasia (New York, N.Y.)|June 29, 2017
Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived XenograftsKristina A Butler, Xiaonan Hou, Marc A Becker, et al.
Cancer Chemotherapy and Pharmacology|August 4, 2009
Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinomaPaul Haluska, Frank Worden, David Olmos, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2010
Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot studySeymur Gahramanov, Ahmed M Raslan, Leslie L Muldoon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 31, 2012
IGFBP ratio confers resistance to IGF targeting and correlates with increased invasion and poor outcome in breast tumorsMarc A Becker, Xiaonan Hou, Sean C Harrington, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2000
Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cellsH R Salih, S G Kosowski, V F Haluska, et al.
Nephrology (Carlton, Vic.)|July 3, 2015
Association between left ventricular global longitudinal strain, health-related quality of life and functional capacity in chronic kidney disease patients with preserved ejection fractionRathika Krishnasamy, Carmel M Hawley, Tony Stanton, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|September 6, 2019
Storage Primes Erythrocytes for Necroptosis and ClearanceWilliam D McCaig, Alexa L Hodges, Matthew A Deragon, et al.
Investigational New Drugs|September 2, 2011
Phase I study of temsirolimus in combination with EKB-569 in patients with advanced solid tumorsAlan H Bryce, Ravi Rao, Jann Sarkaria, et al.
Pageof 37